Rosuvastatin, lycopene and omega-3 fatty acids: A potential treatment for systemic inflammation in COPD; a pilot study

Rosuvastatin, lycopene and omega-3 fatty acids: A potential treatment for systemic inflammation in COPD; a pilot study

Background/Aims: Chronic Obstructive Pulmonary Disease (COPD) is characterized by airway inflammation, in which contributes to loss of lung function. Systemic inflammation is also a feature of COPD contributing to many associated co-morbidities. Statins, omega-3 fatty acids (docosahexanoic acid, DHA...

Full description

Bibliographic Details
Main Authors:	Evan J. Williams, Katherine J. Baines, Joanne M. Smart, Peter G. Gibson, Lisa G. Wood
Format:	Article
Language:	English
Published:	Elsevier 2016-09-01
Series:	Journal of Nutrition & Intermediary Metabolism
Online Access:	http://www.sciencedirect.com/science/article/pii/S2352385915300128

Similar Items

Rosuvastatin, lycopene and omega-3 fatty acids: A potential treatment for systemic inflammation in COPD
by: E.J. Williams, et al.
Published: (2016-06-01)

Omega-3 fatty acids plus rosuvastatin improves endothelial function in South Asians with dyslipidemia
by: Catalin Mindrescu, et al.
Published: (2008-12-01)

Effects of an Encapsulated Fruit and Vegetable Juice Concentrate on Obesity-Induced Systemic Inflammation: A Randomised Controlled Trial
by: Evan J. Williams, et al.
Published: (2017-02-01)

Targeting inflammation in the preterm infant: The role of the omega-3 fatty acid docosahexaenoic acid
by: Naomi H. Fink, et al.
Published: (2016-09-01)

Wound Healing and Omega-6 Fatty Acids: From Inflammation to Repair
by: Jéssica R. Silva, et al.
Published: (2018-01-01)

Changes in Expression of Genes Regulating Airway Inflammation Following a High-Fat Mixed Meal in Asthmatics
by: Qian Li, et al.
Published: (2016-01-01)

Dietary omega-3 fatty acids aid in the modulation of inflammation and metabolic health
by: J. Bruce German, et al.
Published: (2011-07-01)

Dietary ω-6 polyunsaturated fatty acid arachidonic acid increases inflammation, but inhibits ECM protein expression in COPD
by: Sandra Rutting, et al.
Published: (2018-11-01)

Omega-3 fatty acid intake and prevalent respiratory symptoms among U.S. adults with COPD
by: Chantal M. Lemoine S, et al.
Published: (2019-05-01)

The Role of Omega-3 Fatty Acids in the Setting of Coronary Artery Disease and COPD: A Review
by: Alex Pizzini, et al.
Published: (2018-12-01)

Omega-3 fatty acids in psychological disorders
by: D. Ariyasinghe, et al.
Published: (2016-12-01)

Community-acquired pneumonia: biomarkers of inflammation and Omega-3 polyunsaturated fatty acids
by: Burbello A.T., et al.
Published: (2014-03-01)

Omega fatty acids and resolution of inflammation: A new twist in an old tale
by: Mittal Antush, et al.
Published: (2010-01-01)

The Omega-3 Fatty Acid Docosahexaenoic Acid Attenuates Organic Dust-Induced Airway Inflammation
by: Tara M. Nordgren, et al.
Published: (2014-11-01)

Rosuvastatin prevents proteinuria and renal inflammation in nitric oxide-deficient rats
by: Jose Marcos Girardi, et al.
Published: (2011-01-01)

Stimulating the Resolution of Inflammation Through Omega-3 Polyunsaturated Fatty Acids in COVID-19: Rationale for the COVID-Omega-F Trial
by: Hildur Arnardottir, et al.
Published: (2021-01-01)

Glutathione S-transferase omega in the lung and sputum supernatants of COPD patients
by: Salmenkivi Kaisa M, et al.
Published: (2007-07-01)

Influence of Age, Past Smoking, and Disease Severity on TLR2, Neutrophilic Inflammation, and MMP-9 Levels in COPD
by: Jodie L. Simpson, et al.
Published: (2013-01-01)

Lycopene
by: Manal Abdul-Hamid, et al.
Published: (2013-08-01)

Omega-3 Fatty Acids for Depression in Multiple Sclerosis: A Randomized Pilot Study.
by: Lynne Shinto, et al.
Published: (2016-01-01)

Lycopene and Vascular Health
by: Ioana Mozos, et al.
Published: (2018-05-01)

Erythrocyte Omega-3 Fatty Acid Content in Elite Athletes in Response to Omega-3 Supplementation: A Dose-Response Pilot Study
by: Franchek Drobnic, et al.
Published: (2017-01-01)

An Update on Omega-3 Polyunsaturated Fatty Acids and Cardiovascular Health
by: Andrew Elagizi, et al.
Published: (2021-01-01)

Omega-3 Fatty acids and inflammation: novel interactions reveal a new step in neutrophil recruitment.
by: Samantha P Tull, et al.
Published: (2009-08-01)

Omega-3 fatty acids and inflammation: novel interactions reveal a new step in neutrophil recruitment
by: Tull, Samantha P., et al.
Published: (2009)

Optimization of UPLC method for simultaneous determination of rosuvastatin and rosuvastatin degradation products
by: Jure Zakrajšek, et al.
Published: (2017-12-01)

Lycopene and bone: an in vitro investigation and a pilot prospective clinical study
by: Cristina Russo, et al.
Published: (2020-01-01)

Airway β-Defensin-1 Protein Is Elevated in COPD and Severe Asthma
by: Katherine J. Baines, et al.
Published: (2015-01-01)

Update on the Impact of Omega 3 Fatty Acids on Inflammation, Insulin Resistance and Sarcopenia: A Review
by: Alex Buoite Stella, et al.
Published: (2018-01-01)

Omega-3 Fatty Acid Intervention Suppresses Lipopolysaccharide-Induced Inflammation and Weight Loss in Mice
by: Ying-Hua Liu, et al.
Published: (2015-02-01)

Effect of Omega 3 Polyunsaturated Fatty Acids (PUFAs) on Markers of Inflammation in Young Horses in Training
by: Lucia, Jessica Lauren
Published: (2011)

Erythrocyte omega-3 polyunsaturated fatty acid levels are associated with biomarkers of inflammation in older Australians
by: Melinda Olliver, et al.
Published: (2016-09-01)

Microencapsulated foods as a functional delivery vehicle for omega-3 fatty acids: a pilot study
by: David Robert M, et al.
Published: (2009-05-01)

Effect of short chain fatty acids, prebiotics and synbiotics on systemic inflammation: A systematic literature review
by: R. Zapirain, et al.
Published: (2017-06-01)

An adaptogenic role for omega-3 fatty acids in stress; a randomised placebo controlled double blind intervention study (pilot) [ISRCTN22569553]
by: Myers Stephen P, et al.
Published: (2004-11-01)

Current perspectives on rosuvastatin
by: Hu M, et al.
Published: (2013-04-01)

Tomato lycopene prevention of alcoholic fatty liver disease and hepatocellular carcinoma development
by: Camilla P. Stice, et al.
Published: (2018-12-01)

Omega-6 and omega-3 fatty acids: Endocannabinoids, genetics and obesity☆
by: Simopoulos Artemis P.
Published: (2020-01-01)

The omega-6/omega-3 fatty acid ratio: health implications
by: Simopoulos Artemis P.
Published: (2010-09-01)

Reducing cardiovascular risk: an emphasis on rosuvastatin
by: Anikin G.S., et al.
Published: (2017-11-01)

Cannot write session to /tmp/vufind_sessions/sess_qjsk2gdg1rbiodtttnguml9e78